2022年6月博士毕业于金沙2004路线js5。2019年获得国家建设高水平公派研究生项目公派留学资格，赴美国加州大学洛杉矶分校生物工程系联合培养。2022年10月加入金沙2004路线js5生物医学工程研究室。目前作为负责人主持学院和学校博士后基金各1项，近五年参研国家自然科学基金面上项目1项，四川省自然科学基金项目1项。研究成果已陆续发表在期刊Theranostcis，Genes Dis, Regen Biomater等杂志上，授权专利2项。指导本科生开展基础医学创新研究暨实验设计论坛，并协助博士后导师指导研究生科研工作。

研究方向：

1. 心血管疾病的力学生物学调控机制

2. 心血管疾病新型纳/微药物递送策略开发

论文列表：（#为共同一作）

[1] Fei Fang, et al., Song Li*, Yang Shen* and Xiaoheng Liu*. Inflammatory Endothelium-targeted and Cathepsin Responsive Nanoparticles are Effective Against Atherosclerosis. Theranostics. 2022. (IF: 11.6, 封面文章)

[2] Fei Fang, et al., Yang Shen*, Xiaoheng Liu*. Cathepsin K Contributed to Disturbed Flow-induced Atherosclerosis is Dependent on Integrin-actin Cytoskeleton-NF-κB Pathway. Genes Dis. 2022. (IF: 7.4)

[3] Fei Fang, et al., Xiaoheng Liu*, Song Li*. Tuning Macrophages for Atherosclerosis Treatment. Regen Biomater, 2022. (IF: 5.7)

[4] Wei Tang#, Fei Fang#, Ke Liu#, et al.,Yazhou Wang*. Aligned Biofunctional Electrospun PLGA-LysoGM1 Scaffold for Traumatic Brain Injury Repair. Acs Biomater Sci Eng. 2020. (IF: 5.4)

[5] Fei Fang, etal., Yazhou Wang*. Non-invasive Approaches for Drug Delivery to the Brain Based on the Receptor Mediated Transport. Mat Sci Eng C-Mater. 2017. (IF: 8.5)

[6] Tang Feng, Fei Fang, et al., Hongchi Yu*, Xiaoheng Liu*. Fluid shear stress-induced exosomes from liver cancer cells promote activation of cancer-associated fibroblasts via IGF2-PI3K axis. Front Biosci-Landmark. 2022. (IF: 4.0)

[7] Xiaoli Wang, Fei Fang, et al., Yang Shen* and Xiaoheng Liu*. The Combined Contribution of Vascular Endothelial Cell Migration and Adhesion to Stent Re-endothelialization. Front Cell Dev Biol. 2021. (IF: 6.6)